Intravenous Immunoglobulin (IVIg) - 2015 Global Strategic

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Intravenous Immunoglobulin (IVIg) - 2015 Global Strategic Business Report: Hyperimmune Globulin - Taking IVIg Therapy a Step Ahead

Dublin, March 19, 2015 (GLOBE NEWSWIRE) -- Research and Markets ( http://www.researchandmarkets.com/research/mf...ntravenous ) has announced the addition of the "Intravenous Immunoglobulin (IVIg) - Global Strategic Business Report" report to their offering.

This report analyzes the worldwide markets for Intravenous Immunoglobulin (IVIg) in US$ Million and in Kilograms. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World.

Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.

The report profiles 25 companies including many key and niche players such as:

  • Baxter International, Inc. (US)
  • Beijing Tiantan Biological Products Co., Ltd (China)
  • Bharat Serums and Vaccines Limited (India)
  • Biotest AG (Germany)
  • China Biologic Products, Inc (China)
  • Guizhou Taibang Biological Products Co., Ltd (China)
  • CSL Limited (Australia)
  • CSL Behring LLC (US)
  • Grifols, S.A (Spain)
  • Hualan Biological Engineering Inc. (China)
  • Kedrion S.p.A. (Italy)
  • LFB Group (France)
  • Octapharma AG (Switzerland)
  • OMRIX Biopharmaceuticals Ltd (Israel)
  • Shanghai RAAS Blood Products Co., Ltd. (China)
  • Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd (China)

Key Topics Covered:

1. INDUSTRY OVERVIEW

  • Intravenous Immunoglobulin - A Proliferating Biologic
  • List of FDA-Approved and Off-Label Uses of Intravenous Immunoglobulin Therapy
  • Regional Market Perspective
  • Growth Drivers and Market Challenges
  • Competitive Scenario
  • IVIg Products Offered by Global Leading Players (2013)

2. MARKET TRENDS

  • Increasing Awareness of Primary Immunodeficiency Disease to Drive IVIg Market
  • Subcutaneous IG Formulations Gain Therapeutic Foothold
  • Hyperimmune Globulin - Taking IVIg Therapy a Step Ahead
  • IVIg Treatment for Alzheimer's Hindered by Unsuccessful Clinical Trials
  • Synthetic Replacements to IVIg Therapy
  • IVIg Therapy - Home-based vs. Outpatient Settings
  • IVIg Prices to Remain Strong both in the US and Outside the US
  • Per Capita Consumption Rate Varies Across Countries
  • Baxter's Gammagard, the Leading Immunoglobulin Product in the US
  • Strong Demand from Major Indications and Pipeline SCIg Products to Fuel Growth
  • Favorable Reimbursement and High Usage make US the Largest Consumer of Immunoglobulins Worldwide
  • Growing Adoption of Screening Programs to Reduce Usage of Immunoglobulins in the Treatment of SCID
  • Aging Global Population: Major Opportunity Indicator
  • Improving Healthcare Expenditure to Foster Growth

3. PLASMA PROTEINS - AN OVERVIEW

  • Plasma Market Witnesses Surging Demand
  • Regulations Exercise a Tight Rein over Plasma Therapy & Immunoglobulins

4. THERAPY OVERVIEW

  • Immunoglobulins Overview
  • IVIg and SCIg: A Face-off!
  • Cost of Product and Treatment
  • Side-Effects
  • Frequency of Treatment
  • Safety Considerations
  • Patient Response to Treatment Varies
  • Site of Care
  • IVIg Therapy Introduction
  • Intravenous Immunoglobulin
  • Mechanism of IVIg Action
  • IVIg Dosage and Treatment Response Time
  • Common IVIg Intravenous Dosing Recommendations by Indication
  • Complications and Side Effects of Using IVIg
  • Precautions to be Undertaken
  • Intravenous Immunoglobulin - Indications
  • FDA Approved Indications for IVIg
  • Off-Label Usage of IVIg
  • Select Off-Label Indications for IVIg
  • Applications by Medical Specialty
  • Neurology
  • Hematology
  • Immunology
  • Dermatology
  • Nephrology, Rheumatology, Ophthalmology, and Other Diseases

5. REGULATORY APPROVALS

  • CSL Behring Obtains EC Marketing Approval for Privigen® for CIDP Patients
  • CSL Behring Obtains FDA Approval for Privigen® to Treat PID and ITP
  • Biotest Pharmaceuticals Obtains FDA Approval for BIVGAM IVIg
  • Baxter Obtains EC Marketing Approval for HyQvia
  • Green Cross Receives Approval to Commence Phase III Clinical Trials
  • Baxter Bags FDA Approval for GAMMAGARD LIQUID to Treat MMN

6. PRODUCT INNOVATIONS/INTRODUCTIONS

  • Octapharma Canada Introduces Octagam®10% in Canada
  • Biotest Introduces BIVIgAM in the US

7. RECENT INDUSTRY ACTIVITY

  • Emergent BioSolutions Acquires Cangene
  • CMS Begins Evaluation of Payment for In-home IVIG Administration
  • AxelaCare Acquires SCP Specialty Infusion
  • Pfizer to License Gliknik's GL-2045
  • Octapharma Completes Phase II Clinical Trial of Octagam 10% for Alzheimer's
  • Grifols International Establishes New IVIg Purification Facility in Los Angeles
  • Sorrento Therapeutics Secures Global Rights for Using G-MAB® Antibody Library Technology to Produce rIVIg
  • Momenta Pharmaceuticals Acquires Sialic Switch Assets of Virdante Pharmaceuticals
  • Grifols' AMBAR Study Integrates Therapeutic Plasmapheresis with Alternating Infusion of IVIg and Albumin for Treatment of Alzheimer's Disease
  • Biotest Publishes Clinical Trial Data Related to New Investigational IVIg Product

8. FOCUS ON SELECT PLAYERS

9. GLOBAL MARKET PERSPECTIVE

Total Companies Profiled: 25 (including Divisions/Subsidiaries - 30)

  • The United States (10)
  • Japan (1)
  • Europe (7)
  • - France (1)
  • - Germany (1)
  • - The United Kingdom (1)
  • - Italy (1)
  • - Spain (1)
  • - Rest of Europe (2)
  • Asia-Pacific (Excluding Japan) (10)
  • Latin America (1)
  • Middle East (1)

For more information visit http://www.researchandmarkets.com/research/mf...ntravenous


CONTACT: CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Sector: Pharmaceuticals

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tigerlily Brings HIV Information to Women’s Health

Updated Category News Views 99

A stubborn information gap is exactly where Tigerlily Foundation is planting its flag. The nonprofit’s new national HIV education and awareness campaign, THE POWER OF U, expands work that began in breast cancer advocacy into another area where women need clear facts, trusted voices, and room to speak without being shamed for needing answers. This is not a story that...

Continue Reading
KidneyVoter Push Turns Patient Frustration Into Clout

Updated Category News Views 302

A ballot registration drive rarely tells the whole story, but it can reveal where the pressure is building. The American Association of Kidney Patients says its 2026 nonpartisan KidneyVoter™ effort, “50 States in 50 Days,” reached constituencies in every state after launching September 14. That does not produce a clean vote total or prove legislators will suddenly...

Continue Reading
Allooloo's 100M Calls Test Capital Markets AI Data

Updated Category News Views 160

Forty-one point nine thousand issuers is a lot of financial clutter to keep straight, and Allooloo says its machines are getting called on to do precisely that at industrial scale. The Vancouver-based company reported on November 20 that its capital-markets data products now receive 100 million AI-agent calls a month—roughly 3.4 million daily, or 39 per second. That is...

Continue Reading
ASU's International Enrollment Lead Carries Real Weight

Updated Category News Views 108

Twenty thousand nine hundred twenty-six international students is not a campus footnote; it is a serious operating force moving through Arizona State University and the state around it. ASU has held the No. 1 spot among U.S. public universities hosting international students for six straight years, and the 2026 Open Doors report puts it No. 2 across public and private...

Continue Reading
Kinross Lawsuit Puts Round Mountain Claims Under Fire

Updated Category News Views 85

A mine can swallow a rosy forecast faster than any spreadsheet admits. That is the ugly center of the proposed securities class action involving Kinross Gold: not merely that production guidance came down, but the allegation that investors were sold too much confidence before the operational reality at Round Mountain Phase S surfaced. NYSE:KGC dropped from $27.62 on...

Continue Reading
Maryland Handgun Ban Suit Puts Ruger in Legal Crossfire

Updated Category News Views 96

A January Deadline With Real Commercial Teeth Maryland has turned a trigger-design dispute into a fresh legal and retail headache, and the clock is not polite about it. The National Shooting Sports Foundation filed suit against the state over S.B. 334, which is scheduled to take effect Jan. 1, 2027. The law bars sales of certain pistols with cruciform trigger bars,...

Continue Reading
KONST Pitches Asia GPU Uptime as AI Demand Gets Real

Updated Category News Views 115

GPU racks are easy to admire when the lights are on; keeping them useful at 3 a.m. is where the bruises show. KONST arrived at SC26 in Chicago with a sensible pitch for an AI-infrastructure market that is getting less impressed by shiny hardware lists and more obsessed with whether the thing actually works. Its theme, “24/7 GPUs Delivered in Asia,” puts the emphasis...

Continue Reading
Neurelis Founder Earns EY's 2026 Top Entrepreneur Honor

Updated Category News Views 95

Some business awards are wallpaper; this one carries real clinical weight. EY US named Craig Chambliss, CEO and co-founder of Neurelis, its Entrepreneur Of The Year 2026 National Overall Award winner. In a sector where plenty of companies talk grandly about changing lives and then vanish into the regulatory fog, the underlying story matters more than the trophy. Neurelis...

Continue Reading
CASEKOO's Montana Story Makes Brand Purpose Personal

Updated Category News Views 45

A blurry Montana kitchen, not a glossy product render, is doing the heavy lifting for CASEKOO this Thanksgiving. That is either a smart bit of brand discipline or a sentimental detour, depending on whether the company can make people feel something without losing sight of why they bought a phone case in the first place. Warmth Takes the Place of Hardware CASEKOO's new...

Continue Reading
Six LIFE Photographers Bring History Into Florida Focus

Updated Category News Views 72

Seventy photographs can make a pretty loud argument when the historical record has been this lopsided. The Ashley Gibson Barnett Museum of Art at Florida Southern College has brought LIFE: Six Women Photographers to Lakeland, and it deserves more than the usual polite nod given to a traveling museum show. Open since November 14, 2026, and running through March 7, 2027,...

Continue Reading

Top 5 Most Recently Viewed Articles

Future of Energy: Upgrading America's Aging Power Grid

Updated Category News Views 219

The Energy Conundrum Let’s face it, folks, the electric grid we’re using is like a beat-up old car—driving it won’t get any easier unless we pour in some cash and elbow grease. We all know increasing demand for power is putting the squeeze on the infrastructure, and everybody from policymakers to average homeowners is feeling the pinch. Do a little research (or...

Continue Reading
Cove Capital Investments Boosts Annual Distribution Rates Again

Updated Category News Views 69

Cove Capital Investments Announces Distribution Rate Increase The recent announcement regarding the increase in distribution rates by Cove Capital Investments highlights the success of its unique value-add strategy. This strategy is elaborated in the Private Placement Memorandum when the multifamily offering was made available to accredited investors. Performance of Cove...

Continue Reading
Broadcom Surges in After-Hours Trading on Stellar Earnings

Updated Category News Views 268

Broadcom Inc Reports Strong Earnings Broadcom Inc (NASDAQ: AVGO) experienced a remarkable 12.82% increase in its shares during after-hours trading after unveiling its first-quarter results. This rally followed a 6.33% decline during the regular trading hours, which was part of a larger trend of selloffs in the artificial intelligence (AI) chip market. Significant...

Continue Reading
Recent Downgrades: Analysts Weigh In on Key Stocks

Updated Category News Views 162

Analysts' Outlook on Key Stocks Recent changes from top Wall Street analysts revealed a shift in outlook on several prominent companies. Their evaluations often impact market trends and investor sentiment towards various stocks. Invivyd Inc Downgraded D. Boral Capital's Jason Kolbert downgraded the rating for Invivyd Inc (NASDAQ: IVVD) from Buy to Hold. On the trading...

Continue Reading
Innovative Grip Module Redefines Firearm Handling Experience

Updated Category News Views 299

Revolutionizing Firearm Grip with Innovative Design In the realm of firearm accessories, innovation often leads to transformative user experiences. One such breakthrough comes in the form of the 2911 Grip Module. This specially designed grip module addresses the common issues faced by firearm enthusiasts, offering a solution that enhances both comfort and usability. What...

Continue Reading